LY2624803 is a 5-HT2A and histamine H1 receptor antagonist from Eli Lilly as part of its product line-up for therapeutics for the central nervous system. LY2624803 is in phase 2 of clinical trials for the treatment of chronic insomnia. LY2624803 has specific histamine and serotonin receptor antagonism and does not produce other unwanted side effects and it also penetrates into the brain well.
MedKoo Cat#: 581258
Name: LY-2624803
CAS#: 879409-35-5
Chemical Formula: C22H25N3O3
Exact Mass: 379.1896
Molecular Weight: 379.46
Elemental Analysis: C, 69.64; H, 6.64; N, 11.07; O, 12.65
The following data is based on the product molecular weight 379.46 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 1 mM | 1.15 mL | 5.76 mL | 11.51 mL |
| 5 mM | 0.23 mL | 1.15 mL | 2.3 mL |
| 10 mM | 0.12 mL | 0.58 mL | 1.15 mL |
| 50 mM | 0.02 mL | 0.12 mL | 0.23 mL |
